Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Indications of "Bard" PowerPort Isp Implantable Port: Image Accuracy in Resectable Esophageal Cancer Patients

NCT02887261 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.

NCT NCT02887261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02887261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Indications of "Bard" PowerPort Isp Implantable Port: Image Accuracy in Resectable Esophageal Cancer Patients
Lead sponsor
Chang Gung Memorial Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2016
Completion date
May 31, 2019
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

image accuracy, power port